Potential interaction of cadmium chloride with pancreatic mitochondria: Implications for pancreatic cancer.


Journal

International journal of molecular medicine
ISSN: 1791-244X
Titre abrégé: Int J Mol Med
Pays: Greece
ID NLM: 9810955

Informations de publication

Date de publication:
Jul 2019
Historique:
received: 10 04 2019
accepted: 20 05 2019
pubmed: 23 5 2019
medline: 28 11 2019
entrez: 23 5 2019
Statut: ppublish

Résumé

Pancreatic cancer (PC) is insidious with a high mortality rate due to the lack of symptomology prior to diagnosis. Mitochondrial involvement in PC development is becoming accepted, and exposure to cadmium (Cd) is suspected of being a risk factor for the development of PC; however, the mechanisms involved remain unclear. In this study, we examined the role of Cd as a mitochondrial toxicant and whether alterations in mitochondrial function may be an underlying cause for the development of PC. In this study, cadmium chloride (CdCl2)‑mediated toxicity in hTERT‑HPNE and AsPC‑1 pancreatic cell lines was determined by MTT assay. We also investigated the release of LDH and the generation of free radicals. Mitochondrial toxicity assays were performed in media containing glucose (25 mM) or galactose (10 mM) and following exposure to CdCl2 (0‑100 µM) followed by MTT assay. For the confirmation of mitochondrial toxicity, we measured the release of ATP following exposure to CdCl2. Initial experiments confirmed that exposure to CdCl2 did not reduce the viability of either cell line until a concentration of >10 µM was used. Non‑linear analysis of the response curves revealed lethal concentration 50% (LC50) values for CdCl2 in the HPNE cells of 77 µM compared to 42 µM in the AsPC‑1 cells (P<0.01). The CdCl2‑mediated mitochondrial toxic effects were greater in the HPNE cells, suggesting a heightened sensitivity to the effects of CdCl2, not due to elevated oxidative stress. Increased mitochondrial toxic sensitivity was indicated by a 73.4% reduction in IC50 values in the HPNE cells cultured in galactose compared to culture in glucose media, whereas the AsPC‑1 cells exhibited a 58.8% reduction in IC50 values. In addition, the higher concentration of CdCl2 elicited a significant cell‑dependent effect on ATP release in both cell lines, suggestive of CdCl2 being a mitochondrial toxicant. Cell survival was unaffected following exposure to low concentrations of CdCl2; however, exposure did alter mitochondrial function (control cells > tumor cells). Therefore, the findings of this study indicate that the mitochondria may be a site of action for cadmium in promoting tumor development.

Identifiants

pubmed: 31115542
doi: 10.3892/ijmm.2019.4204
pmc: PMC6559323
doi:

Substances chimiques

Cytotoxins 0
Cadmium Chloride J6K4F9V3BA

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

145-156

Références

Eur J Biochem. 2001 Apr;268(8):2512-9
pubmed: 11298771
Environ Health Perspect. 2001 Sep;109(9):909-13
pubmed: 11673119
Curr Top Med Chem. 2001 Dec;1(6):529-39
pubmed: 11895129
Crit Rev Oncol Hematol. 2002 Apr;42(1):93-103
pubmed: 11923071
Int J Gastrointest Cancer. 2002;32(1):23-30
pubmed: 12630766
Toxicol In Vitro. 2004 Feb;18(1):55-61
pubmed: 14630062
Toxicology. 2003 Dec 15;194(1-2):19-33
pubmed: 14636693
Mutat Res. 2003 Dec 10;533(1-2):107-20
pubmed: 14643415
Cancer Res. 2004 Feb 1;64(3):985-93
pubmed: 14871829
Int J Gastrointest Cancer. 2003;34(1):27-38
pubmed: 15235133
Biometals. 2004 Oct;17(5):555-8
pubmed: 15688863
Toxicol Appl Pharmacol. 2005 Sep 1;207(2):179-86
pubmed: 16102569
Toxicol Lett. 2006 Jan 5;160(2):171-7
pubmed: 16111842
Chem Biol Interact. 2006 Mar 10;160(1):1-40
pubmed: 16430879
Biochimie. 2006 Nov;88(11):1549-59
pubmed: 17070979
Sci Total Environ. 2007 Feb 1;373(1):77-81
pubmed: 17175009
Biol Trace Elem Res. 2006 Winter;114(1-3):281-91
pubmed: 17206009
Toxicol Sci. 2007 Jun;97(2):539-47
pubmed: 17361016
Anal Biochem. 2007 Jul 15;366(2):197-206
pubmed: 17512890
Cell Biol Toxicol. 2008 Jan;24(1):55-62
pubmed: 17610031
Int J Occup Environ Health. 2007 Apr-Jun;13(2):202-12
pubmed: 17718178
J Trace Elem Med Biol. 2008;22(1):66-72
pubmed: 18319143
Mutat Res. 2009 Mar 31;674(1-2):3-22
pubmed: 19114126
Mitochondrion. 2009 Nov;9(6):377-84
pubmed: 19706341
Biometals. 2010 Oct;23(5):927-40
pubmed: 20361350
Toxicol Lett. 2010 Sep 15;198(1):49-55
pubmed: 20417263
Biochim Biophys Acta. 2011 Jun;1807(6):568-76
pubmed: 20804724
Biochim Biophys Acta. 2011 Jun;1807(6):534-42
pubmed: 20849810
Hum Exp Toxicol. 2011 Aug;30(8):920-9
pubmed: 20876161
Biochim Biophys Acta. 2011 Jun;1807(6):620-5
pubmed: 21074512
J Appl Toxicol. 2012 May;32(5):318-32
pubmed: 22161274
Food Chem Toxicol. 2012 Mar;50(3-4):552-7
pubmed: 22240416
Gene. 2012 Apr 10;497(1):27-37
pubmed: 22310389
ScientificWorldJournal. 2012;2012:572514
pubmed: 22701362
Oncol Lett. 2010 May;1(3):565-568
pubmed: 22966344
Exp Ther Med. 2012 Mar;3(3):423-432
pubmed: 22969906
Arh Hig Rada Toksikol. 2012 Sep;63(3):247-54
pubmed: 23152374
IARC Monogr Eval Carcinog Risks Hum. 2012;100(Pt E):1-538
pubmed: 23193840
PLoS One. 2013;8(2):e54374
pubmed: 23405080
Ann Intensive Care. 2013 Feb 15;3(1):4
pubmed: 23414610
Toxicol Lett. 2013 Aug 14;221(2):83-90
pubmed: 23792431
ScientificWorldJournal. 2013 Jun 03;2013:394652
pubmed: 23844395
PLoS One. 2013 Sep 17;8(9):e75087
pubmed: 24069382
J Nanopart Res. 2013;15:1829
pubmed: 24078789
J Biol Chem. 1987 Dec 5;262(34):16333-7
pubmed: 2445745
Redox Biol. 2014 Jan 10;2:224-33
pubmed: 24494197
Environ Sci Pollut Res Int. 2014 Sep;21(18):10561-73
pubmed: 24894749
Genes (Basel). 2014 Sep 26;5(4):865-86
pubmed: 25264560
Food Chem Toxicol. 2015 Apr;78:130-40
pubmed: 25681546
Fungal Genet Biol. 2015 Sep;82:95-103
pubmed: 26164373
Toxicol Lett. 2015 Dec 3;239(2):90-6
pubmed: 26367466
Environ Sci Pollut Res Int. 2015 Nov;22(22):17465-74
pubmed: 26423282
Environ Int. 2016 Jan;86:1-13
pubmed: 26479829
Toxicol In Vitro. 2015 Dec 25;30(1 Pt B):300-8
pubmed: 26498060
Biochim Biophys Acta. 2016 Aug;1857(8):1139-1146
pubmed: 27066942
Mol Med Rep. 2016 Jun;13(6):4943-9
pubmed: 27121414
J Cancer. 2016 Apr 26;7(7):817-22
pubmed: 27162540
Int J Biochem Cell Biol. 2016 Oct;79:128-138
pubmed: 27590850
Toxicol Appl Pharmacol. 2016 Nov 1;310:150-158
pubmed: 27634459
Arh Hig Rada Toksikol. 2017 Mar 1;68(1):38-45
pubmed: 28365673
J Toxicol Sci. 2017;42(3):349-358
pubmed: 28496041
Environ Res. 2017 Aug;157:173-181
pubmed: 28570961
Sci Total Environ. 2017 Dec 1;601-602:741-755
pubmed: 28577409
IUBMB Life. 2017 Nov;69(11):824-833
pubmed: 28940845
Environ Sci Pollut Res Int. 2018 Feb;25(4):3211-3232
pubmed: 29230653
Environ Int. 2018 Apr;113:300-305
pubmed: 29338949
Biomed Res Int. 2017;2017:1981837
pubmed: 29349066
Cell Cycle. 2018;17(6):688-701
pubmed: 29509056
Toxics. 2018 Mar 10;6(1):null
pubmed: 29534455
Int J Mol Sci. 2018 May 17;19(5):null
pubmed: 29772829
CA Cancer J Clin. 2018 Nov;68(6):394-424
pubmed: 30207593
Food Chem Toxicol. 2019 Feb;124:439-449
pubmed: 30572062
Int J Environ Res Public Health. 2019 Jan 18;16(2):
pubmed: 30669347
Environ Int. 2019 Jul;128:353-361
pubmed: 31078004
Free Radic Biol Med. 1995 Feb;18(2):321-36
pubmed: 7744317

Auteurs

David R Wallace (DR)

Department of Pharmacology, School of Biomedical Science, Oklahoma State University Center for Health Sciences, Tulsa, OK 74107-1898, USA.

Demetrios A Spandidos (DA)

Laboratory of Clinical Virology, School of Medicine, University of Crete, 71003 Heraklion, Greece.

Aristidis Tsatsakis (A)

Department of Toxicology and Forensics, School of Medicine, University of Crete, 71003 Heraklion, Greece.

Amie Schweitzer (A)

Department of Pharmacology, School of Biomedical Science, Oklahoma State University Center for Health Sciences, Tulsa, OK 74107-1898, USA.

Vladimir Djordjevic (V)

First Surgical Clinic, Clinical Center of Serbia, 11000 Belgrade, Serbia.

Aleksandra Buha Djordjevic (AB)

Department of Toxicology 'Akademik Danilo Soldatović', Faculty of Pharmacy, University of Belgrade, 11000 Belgrade, Serbia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH